ANAPTYSBIO, INC
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
ANAB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US0327241065
- LEI:
- Country:
- United States of America
- Address:
- 10770 WATERIDGE CIRCLE, SUITE 210, 92121 SAN DIEGO
- Website:
- https://www.anaptysbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AnaptysBio, Inc. is a clinical-stage biotechnology company that develops innovative immunology therapeutics for autoimmune and inflammatory diseases. The company's pipeline includes rosnilimab, a pathogenic T cell depleter in Phase 2b trials for rheumatoid arthritis, and ANB033, a CD122 antagonist. AnaptysBio has announced plans to separate its biopharmaceutical operations from its royalty assets into two independent, publicly traded companies by year-end 2026 to align with different investor strategies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ANAPTYSBIO, INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ANAPTYSBIO, INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ANAPTYSBIO, INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
